Bright Minds Biosciences (DRUG) EPS (Basic): 2019-2021
Historic EPS (Basic) for Bright Minds Biosciences (DRUG) over the last 3 years, with Sep 2021 value amounting to -$0.76.
- Bright Minds Biosciences' EPS (Basic) fell 1716.79% to -$1.33 in Q3 2021 from the same period last year, while for Sep 2021 it was -$0.81, marking a year-over-year change of. This contributed to the annual value of -$0.76 for FY2021, which is 885.37% down from last year.
- According to the latest figures from FY2021, Bright Minds Biosciences' EPS (Basic) is -$0.76, which was down 885.37% from $0.10 recorded in FY2020.
- Bright Minds Biosciences' 5-year EPS (Basic) high stood at $0.10 for FY2020, and its period low was -$0.76 during FY2021.
- In the last 3 years, Bright Minds Biosciences' EPS (Basic) had a median value of $0.03 in 2019 and averaged -$0.21.
- Its EPS (Basic) has fluctuated over the past 5 years, first soared by 219.14% in 2020, then slumped by 885.37% in 2021.
- Bright Minds Biosciences' EPS (Basic) (Yearly) stood at $0.03 in 2019, then soared by 219.14% to $0.10 in 2020, then plummeted by 885.37% to -$0.76 in 2021.